Obestatin

From WikiMD's WELLNESSPEDIA

Obestatin is a peptide hormone that is produced in the gastrointestinal tract. It was discovered in 2005 and is encoded by the same gene that produces ghrelin, a hormone that stimulates appetite. Obestatin, in contrast, is believed to suppress appetite, although its exact role in the body is still under investigation.

Structure and Function[edit]

Obestatin is a 23-amino acid peptide that is derived from the preproghrelin molecule, which also gives rise to ghrelin. The obestatin peptide is encoded by the ghrelin gene, but it is produced by a different set of post-translational modifications.

Obestatin is believed to function as an anorexigenic hormone, meaning that it suppresses appetite. This is in contrast to ghrelin, which is an orexigenic hormone that stimulates appetite. However, the exact role of obestatin in the body is still not fully understood, and some studies have questioned whether it truly has an anorexigenic effect.

Research and Clinical Significance[edit]

Since its discovery in 2005, obestatin has been the subject of extensive research. Some studies have suggested that it may play a role in the regulation of body weight and energy homeostasis, as well as in the regulation of insulin secretion and glucose metabolism.

In addition, there is some evidence that obestatin levels may be altered in certain diseases. For example, some studies have found that obestatin levels are decreased in individuals with obesity and type 2 diabetes, suggesting that it may play a role in these conditions. However, more research is needed to fully understand the clinical significance of obestatin.

See Also[edit]

References[edit]

Obestatin[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.